
浏览全部资源
扫码关注微信
400037 重庆,陆军军医大学(第三军医大学)第二附属医院全军心血管外科研究所
[ 王咏,E-mail: wy003236@163.com WANG Yong, E-mail: wy003236@163.com
收稿:2020-09-14,
修回:2020-11-27,
纸质出版:2021-01-30
移动端阅览
刘凌超, 唐富琴, 李畑波, 等. 主动脉瓣二叶畸形行主动脉瓣置换术后疗效的中期随访研究——基于倾向性评分匹配法分析[J]. 第三军医大学学报, 2021,43(2):101-108.
Lingchao LIU, Fuqin TANG, Tianbo LI, et al. Efficacy of aortic valve replacement for bicuspid aortic valve: a medium-term follow-up study based on propensity score matching analysis[J]. Journal of Third Military Medical University, 2021, 43(2): 101-108.
刘凌超, 唐富琴, 李畑波, 等. 主动脉瓣二叶畸形行主动脉瓣置换术后疗效的中期随访研究——基于倾向性评分匹配法分析[J]. 第三军医大学学报, 2021,43(2):101-108. DOI: 10.16016/j.1000-5404.202009112.
Lingchao LIU, Fuqin TANG, Tianbo LI, et al. Efficacy of aortic valve replacement for bicuspid aortic valve: a medium-term follow-up study based on propensity score matching analysis[J]. Journal of Third Military Medical University, 2021, 43(2): 101-108. DOI: 10.16016/j.1000-5404.202009112.
目的
2
探讨主动脉瓣二叶畸形(bicuspid aortic valve
BAV)与三叶主动脉瓣(tricuspid aortic valve
TAV)患者行主动脉瓣机械瓣置换(aortic valve replacement,AVR)术后中期疗效差异及影响因素。
方法
2
回顾性分析2014年1月至2019年6月在陆军军医大学第二附属医院行AVR的245例患者临床资料,分为两组:TAV组,158例;BAV组,87例,其中0型Ap 15例,0型Lat 21例,1型45例,2型6例。采用1:1倾向性评分匹配法(propensity score matching method
PSM)筛选匹配队列并比较术中、围手术期及随访结局。多因素Logistic回归分析用于评估影响升主动脉继续扩张的因素。
结果
2
PSM筛选出了69对匹配队列并平衡了两组之间的基线差异(
P
>
0.05)。两组患者的术中及围手术期结局差异均无统计学意义。在45个月中位随访期间,两组升主动脉直径、主动脉窦部直径及其变化情况、主动脉不良事件发生率、人工瓣膜的功能状态及心功能分级差异均无统计学意义,而BAV组升主动脉变化差值、年变化率以及升主动脉继续扩张人数的比例均显著高于TAV组(
P
=0.016、0.010、0.041)。PSM队列经多因素Logistic回归分析显示,BAV分类(
OR
=3.296,95%
CI
: 1.473~7.372)、主动脉瓣单纯反流(
OR
=6.491,95%
CI
: 2.691~15.657)及主动脉瓣狭窄伴反流(
OR
=8.233,95%
CI
: 2.565~26.429)与AVR术后升主动脉继续扩张存在独立正相关。进一步在PSM队列中筛选出BAV队列,多因素Logistic回归分析显示,1型BAV分型(
OR
=10.378,95%
CI
: 1.587~67.853)、吸烟史(
OR
=4.959,95%
CI
: 1.158~21.231)以及主动脉瓣单纯反流(
OR
=8.070,95%
CI
: 1.729~37.674)与AVR术后升主动脉继续扩张存在独立正相关。
结论
2
BAV相较于TAV患者在AVR置换术后更容易发生升主动脉的继续扩张。1型BAV分型、吸烟史及主动脉瓣反流是BAV患者AVR术后升主动脉继续扩张的独立危险因素。
Objective
2
To investigate the differences and factors influencing the medium-term outcomes of aortic valve replacement (AVR) between bicuspid aortic valve (BAV) and tricuspid aortic valve (TAV) patients.
Methods
2
A total of 245 patients who underwent AVR in our hospital from January 2014 to June 2019 and met our inclusion criteria were retrospectively recruited in this study
and were divided into TAV group (
n
=158) and BAV group (
n
=87)
including 15 cases of type 0 Ap
21 cases of type 0 Lat
45 cases of type 1
and 6 cases of type 2. The 1:1 propensity score matching method (PSM) was used to screen the matching cohort
and the intraoperative
perioperative and follow-up outcomes were compared. Multivariate Logistic regression analysis was performed to evaluate the factors affecting
the continued dilation of the ascending aorta.
Results
2
After PSM
69 pairs of matching cohorts were selected and the baseline data of the 2 groups were basically balanced. Intraoperative and perioperative outcomes did not differ between the 2 groups. During the median follow-up time of 45 months
there were no significant differences in the diameter of the ascending aorta
diameter of the aortic sinus and its changes
incidence of adverse aortic events
functional status of the prosthetic valve
and classification of cardiac function between the 2 groups
while the difference of ascending aorta change
annual change rate
and proportion of continuous dilation of ascending aorta were significantly higher in the BAV group than the TAV group (
P
=0.016
0.010
0.041). Multivariate Logistic regression analysis of PSM cohort showed that BAV types (
OR
=3.296
95%
CI
: 1.473~7.372)
aortic regurgitation (
OR
=6.491
95%
CI
: 2.691~15.657) and aortic valve stenosis with regurgitation (
OR
=8.233
95%
CI
: 2.565~26.429) were positively correlated with the continued dilatation of the ascending aorta after AVR. Furthermore
after the BAV cohort was screened out from the PSM cohort
multivariate Logistic regression analysis indicated that type 1 in BAV (
OR
=10.378
95%
CI
: 1.587~67.853)
smoking (
OR
=4.959
95%
CI
: 1.158~21.231) and aortic regurgitation (
OR
=8.070
95%
CI
: 1.729~37.674) were positively correlated with the continued dilatation of the ascending aorta after AVR in BAV patients.
Conclusion
2
BAV patients are more likely to continue to dilate the ascending aorta after AVR when compared with TAV patients
and type 1 in BAV
smoking and aortic regurgitation are independent risk factors in BAV patients.
HOFFMAN J I, KAPLAN S. The incidence of congenital heart disease[J]. J Am Coll Cardiol, 2002, 39(12): 1890-1900. DOI: 10.1016/s0735-1097(02)01886-7.
BORGER M A, FEDAK P W M, STEPHENS E H, et al . The American Association for Thoracic Surgery consensus guidelines on bicuspid aortic valve-relatedaortopathy: Full online-only version[J ] . J Thorac Cardiovasc Surg, 2018, 156(2): e41-e74. DOI: 10.1016/j.jtcvs.2018.02.115.
SIEVERS H H, SCHMIDTKE C. A classification system for the bicuspid aortic valve from 304 surgical specimens[J]. J Thorac Cardiovasc Surg, 2007, 133(5): 1226-1233. DOI: 10.1016/j.jtcvs.2007.01.039.
SIU S C, SILVERSIDES C K. Bicuspid aortic valve disease[J]. J Am Coll Cardiol, 2010, 55(25): 2789-2800. DOI: 10.1016/j.jacc.2009.12.068.
HIRATZKA L F, CREAGER M A, ISSELBACHER E M, et al . Surgery for aortic dilatation in patients with bicuspid aortic valves: A statement of clarification from the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines[J ] . J Am Coll Cardiol, 2016, 67(6): 724-731. DOI: 10.1016/j.jacc.2015.11.006.
EL-HAMAMSY I, YACOUB M H. A measured approach to managing the aortic root in patients with bicuspid aortic valve disease[J]. Curr Cardiol Rep, 2009, 11(2): 94-100. DOI: 10.1007/s11886-009-0015-y.
GIRDAUSKAS E, ROUMAN M, DISHA K, et al . Aortic dissection after previous aortic valve replacement for bicuspid aortic valvedisease[J ] . J Am Coll Cardiol, 2015, 66(12): 1409-1411. DOI: 10.1016/j.jacc.2015.07.022.
GIRDAUSKAS E, DISHA K, RAISIN H H, et al . Risk of late aortic events after an isolated aortic valve replacement for bicuspid aortic valve Stenosis with concomitant ascending aortic dilation[J ] . Eur J Cardiothorac Surg, 2012, 42(5): 832-838. DOI: 10.1093/e jcts/ezs137.
焦明旭, 张晓, 刘迪, 等.倾向性评分匹配在非随机对照研究中的应用[J].中国卫生统计, 2016, 33(2): 350-352.
JIAO M X, ZHANG X, LIU D, et al .Application of propensity score matching in non-randomized controlled studies[J ] . Chin J Heal Stat, 2016, 33(2): 350-352.
NASHEF S A, ROQUES F, SHARPLES L D, et al . EuroSCORE Ⅱ[J ] . Eur J Cardiothorac Surg, 2012, 41(4): 734-745. DOI: 10.1093/ejcts/ezs043.
MASRI A, KALAHASTI V, ALKHARABSHEH S, et al . Characteristics and long-term outcomes of contemporary patients with bicuspid aortic valves[J ] . J Thorac Cardiovasc Surg, 2016, 151(6): 1650-1659.e1. DOI: 10.1016/j.jtcvs.2015.12.019.
BORGER M, PRESTON M, IVANOV J, et al . Should the ascending aorta be replaced more frequently in patients with bicuspid aortic valve disease?[J ] . J Thorac Cardiovasc Surg, 2004, 128(5): 677-683. DOI: 10.1016/s0022-5223(04)00984-5.
MATSUYAMA S, NISHIDA T, USHIJIMA T, et al . Long-term results after treatment of the ascending aorta for bicuspid aortic valve patients[J ] . Surg Today, 2016, 46(6) : 729-734. DOI: 10.1007/s00595-015-1274-4.
KANEKO T, SHEKAR P, IVKOVIC V, et al . Should the dilated ascending aorta be repaired at the time of bicuspid aortic valve replacement?[J ] . Eur J Cardiothorac Surg, 2018, 53(3): 560-568. DOI: 10.1093/ejcts/ezx387.
MAHADEVIA R, BARKER A J, SCHNELL S, et al . Bicuspid aortic cusp fusion morphology alters aortic three-dimensional outflow patterns, wall shear stress, and expression of aortopathy[J ] . Circulation, 2014, 129(6): 673-682. DOI: 10.1161/circulationaha.113.003026.
YASUDA H. Failure to prevent progressive dilation of ascending aorta by aortic valve replacement in patients with bicuspid aortic valve: comparison with tricuspid aortic valve[J]. Circulation, 2003, 108(90101): 291-294. DOI: 10.1161/01.cir.0000087449.03964.fb.
WANG Y, WU B, LI J, et al . Impact of aortic insufficiency on ascending aortic dilatation and adverse aortic events after isolated aortic valve replacement in patients with a bicuspid aortic valve[J ] . Ann Thorac Surg, 2016, 101(5): 1707-1714. DOI: 10.1016/j.athoracsur.2015.10.047.
CHIM Y H, DAVIES H A, MASON D, et al . Bicuspid valve aortopathy is associated with distinct patterns of matrix degradation[J ] . J Thorac Cardiovasc Surg, 2020, 160(6): e239-e257. DOI: 10.1016/j.jtcvs.2019.08.094.
MAGUIRE E M, PEARCE S, XIAO R, et al . Matrix metalloproteinase in abdominal aortic aneurysm and aortic dissection[J ] . Pharmaceuticals (Basel), 2019, 12(3): 118
[RABKIN S W. The role matrix metalloproteinases in the production of aortic aneurysm[M ] //Progress in molecular biology and translational science. Amsterdam: Elsevier, 2017: 239-265. DOI: 10.1016/bs.pmbts.2017.02.002 http://dx.doi.org/10.1016/bs.pmbts.2017.02.002 .
IKONOMIDIS J S, RUDDY J M, BENTON S M Jr, et al . Aortic dilatation with bicuspid aortic valves: cusp fusion correlates to matrix metalloproteinases and inhibitors[J ] . Ann Thorac Surg, 2012, 93(2): 457-463. DOI: 10.1016/j.athoracsur.2011.09.057.
WANG S X, ZHANG C, ZHANG M, et al . Activation of AMP-activated protein kinase α2 by nicotine instigates formation of abdominal aortic aneurysms in mice in vivo [J ] . Nat Med, 2012, 18(6): 902-910. DOI: 10.1038/nm.2711..
GU B H, CHOI J C, SHEN Y H, et al . Elastin-specific autoimmunity in smokers with thoracic aortic aneurysm and dissection is independent of chronic obstructive pulmonary disease[J ] . J Am Heart Assoc, 2019, 8(8): 1-10. DOI: 10.1161/jaha.118.011671.
BIAGGI P, MATTHEWS F, BRAUN J, et al . Gender, age, and body surface area are the major determinants of ascending aorta dimensions in subjects with apparently normal echocardiograms[J ] . J Am Soc Echocardiogr, 2009, 22(6): 720-725. DOI: 10.1016/j.echo.2009.03.012.
STOCK S, MOHAMED S A, SIEVERS H H. Bicuspid aortic valve related aortopathy[J]. Gen Thorac Cardiovasc Surg, 2019, 67(1): 93-101. DOI: 10.1007/s11748-017-0821-x.
DEVEJA R P, ILIOPOULOS D C, KRITHARIS E P, et al . Effect of aneurysm and bicuspid aortic valve on layer-specific ascending aorta mechanics[J ] . Ann Thorac Surg, 2018, 106(6): 1692-1701. DOI: 10.1016/j.athoracsur.2018.05.071.
NISHIMURA R A, OTTO C M, BONOW R O, et al . 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines[J ] . J Am Coll Cardiol, 2014, 63(22): e57-e185. DOI: 10.1016/j.j acc.2014.02.536.
ELEFTERIADES J A, MUKHERJEE S K, MOJIBIAN H. Discrepancies in measurement of the thoracic aorta[J]. J Am Coll Cardiol, 2020, 76(2): 201-217. DOI: 10.1016/j.jacc.2020.03.084.
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621